TOKYO - Chugai Pharmaceutical Co., Ltd. (TOKYO: 4519) announced the following personnel changes, effective March 29 and April 1, 2022 respectively.

[Details of Personnel Changes]

Effective March 29, 2022

Directors

Name

New Responsibilities

Current Responsibilities

Osamu Okuda

Representative Director, President

Chief Executive Officer (CEO)

Supervisory responsibility for Corporate Planning, Partnering, External Affairs and Audit

In charge of Corporate Planning Dept., External Affairs Dept., and Audit Dept.

Representative Director, President

Chief Executive Officer (CEO)

Supervisory responsibility for Clinical Development, Pharmaceutical Technology, Drug Safety, Medical Affairs, Marketing & Sales and Foundation Medicine

Hisafumi Yamada

Director, Executive Vice President

Supervisory responsibility for Project & Lifecycle Management (R&D), Research, Translational Research, Clinical Development and Pharmaceutical Technology

Executive Vice President

Supervisory responsibility for Project & Lifecycle Management (R&D), Research and Translational Research

Toshiaki Itagaki

Director, Executive Vice President

Chief Financial Officer (CFO)

Supervisory responsibility for Finance & Accounting, Corporate Communication and Purchasing

Head of Finance Supervisory Div.

Executive Vice President

Chief Financial Officer (CFO)

Supervisory responsibility for Finance & Accounting, Corporate Communication, Purchasing and Digital Transformation

Head of Finance Supervisory Div.

The appointment of Osamu Okuda as Chairman of the Board of Directors is subject to approval at the Board of Directors Meeting, which is scheduled to be convened on March 29, 2022.

The appointment of Hisafumi Yamada and Toshiaki Itagaki as Directors is subject to approval at the 111th Annual General Meeting of Shareholders, which is scheduled to be convened on March 29, 2022.

Tatsuro Kosaka is scheduled to retire from Representative Director, Chairman as of March 29, 2022 to be appointed as Senior Advisor.

Motoo Ueno is scheduled to retire from Representative Director, Deputy Chairman as of March 29, 2022 to be appointed as Senior Advisor.

Contact:

Media

Chugai Pharmaceutical Co., Ltd.

Media Relations Group

Corporate Communications Dept.

Tomoko Shimizu

Tel: +81-3-3273-0881

E-mail: pr@chugai-pharm.co.jp

Investors

Chugai Pharmaceutical Co., Ltd.

Investor Relations Group

Corporate Communications Dept.

Takayuki Sakurai

Tel: +81-3-3273-0554

E-mail: ir@chugai-pharm.co.jp

(C) 2022 Electronic News Publishing, source ENP Newswire